Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 2: The Path to Bedside Management

Rezaei, Nima, Hanaei, Sara

  • 出版商: Springer
  • 出版日期: 2024-08-03
  • 售價: $4,640
  • 貴賓價: 9.5$4,408
  • 語言: 英文
  • 頁數: 739
  • 裝訂: Quality Paper - also called trade paper
  • ISBN: 3031237072
  • ISBN-13: 9783031237072
  • 海外代購書籍(需單獨結帳)

相關主題

商品描述

This book aims to gather the current knowledge regarding different aspects of brain and spinal cord tumors in order to more efficiently help the patients. Brain tumors comprise about 5-9% of all human neoplasms; and the central nervous system (CNS) neoplasms are ranked among the most prevalent neoplasms of childhood as well. The more we know about the nature and characteristic of brain and spinal cord tumors, the more precise decision could be made for each patient, in order to reach the best outcome. While surgical resection, chemotherapy, and radiotherapy have been considered as the standards of care for benign and/or malignant CNS tumors since a long time ago, new therapeutic approaches such as immunotherapy have been recently proposed to be considered for treatment of CNS tumors, especially as in some cases, the tumors might be inoperable or the patient may not benefit from other treatment modalities after several recurrences.

The second volume of the book focuses on clinical aspects of these tumors. Accordingly, the most important brain and spinal cord tumors are specifically discussed in each chapter based on a rational outlining for all chapter in this volume: Background and epidemiology, genetics, immunology and molecular biology, histopathology and morphology, imaging and radiologic features, clinical manifestations, therapeutic approaches, surgical intervention, chemotherapy and radiotherapy, new therapeutic modalities, follow-up, and prognosis. The chapters of this volume discuss the following pathologies of brain and spinal cord tumors: malignant glioma, benign glioma, meningiomas and other meningeal tumors, ependymomas, medulloblastomas, pineal tumors, choroid plexus and ventricular tumors, neuroectodermal tumors of CNS, neuroepithelial tumors of CNS, pituitary gland tumors, craniopharyngioma, schwannomas and nerve-sheet tumors, hemangioblastomas and other vascular originating tumors, brain and spinal tumors of embryonic origin, germ line cell tumors, malignant bone or cartilage-originating tumors of brain and spine, benign bone or cartilage-originating tumors of brain and spine, brain tumors affecting the orbit globe and orbit tumors affecting the brain, CNS lymphomas, metastatic lesions of the brain and spine, malignant spinal tumors, benign spinal tumors, brain and/or spinal cord tumors accompanied with other diseases or syndromes, psychological and psychiatric aspects of brain and spinal cord tumors, a brief explanation on surgical approaches for treatment of different brain tumors. This volume of book is useful for physicians of different specialties, mainly neurosurgeons, neurologists, neuropathologists, and neuroradiologists.


作者簡介

Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founding President of Universal Scientific Education and Research Network (USERN). Prof. Rezaei has already been the Director of more than 100 research projects and has designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than 40 internationaljournals. He has edited more than 50 international books, has presented more than 500 lectures/posters in congresses/meetings, and has published more than 1,100 scientific papers in the international journals.

Dr. Sara Hanaei started medicine at TUMS in 2010 and started a master of public health (MPH) in 2014. She graduated with MD-MPH in 2018. She also received TUMS Research Diploma (TUMS-RD) in a 2-year study period from 2013-2015. She was a research assistant at Research Center for Immunodeficiencies (RCID) from 2018-2021 and further continued neurosurgery as a clinical specialty at TUMS in 2021. She has experience in teaching research skills to students.

Medical research was one of her greatest interests since the beginning of her academic education, especially in the fields of Neurosurgery and Immunology, therefore, she started research in those fields. Over the past decade, she contributed to different research projects, books, and other research activities including instructing research workshops in statistics, systematic reviews, and meta-analysis. She got involved in executive tasks and developed some executive skills through membership in the Universal Scientific Education and Research Network (USERN), where she experienced organizing scientific events, congresses, festivals, scoring, rankings, etc.

作者簡介(中文翻譯)

尼瑪·雷扎伊教授(Professor Nima Rezaei)於德黑蘭醫科大學獲得醫學學位(MD),隨後在英國謝菲爾德大學獲得分子與遺傳醫學碩士(MSc)及臨床免疫學與人類遺傳學博士(PhD)。他還在紐卡斯爾綜合醫院完成了兒科臨床免疫學與骨髓移植的短期研究獎學金。雷扎伊教授目前是德黑蘭醫科大學免疫學的全職教授及研究與技術副院長,並且是免疫缺陷研究中心的共同創辦人及負責人。他也是全球科學教育與研究網絡(USERN)的創始會長。雷扎伊教授已經擔任超過100個研究項目的主任,並設計及參與多個國際合作項目。他是超過40本國際期刊的編輯、編輯助理或編輯委員會成員,編輯了超過50本國際書籍,並在會議中發表了超過500場講座/海報,已在國際期刊上發表超過1,100篇科學論文。

薩拉·哈納伊博士(Dr. Sara Hanaei)於2010年在德黑蘭醫科大學開始學習醫學,並於2014年開始攻讀公共衛生碩士(MPH)。她於2018年獲得MD-MPH學位,並在2013至2015年的兩年學習期間獲得德黑蘭醫科大學研究文憑(TUMS-RD)。她於2018至2021年擔任免疫缺陷研究中心(RCID)的研究助理,並於2021年繼續在德黑蘭醫科大學攻讀神經外科臨床專業。她在教授學生研究技能方面擁有經驗。

醫學研究自她學術教育開始以來就是她最大的興趣之一,特別是在神經外科和免疫學領域,因此她開始在這些領域進行研究。在過去十年中,她參與了不同的研究項目、書籍及其他研究活動,包括教授統計學、系統性回顧和元分析的研究工作坊。她通過參加全球科學教育與研究網絡(USERN)獲得了一些執行技能,並參與了科學活動、會議、節慶、評分、排名等的組織工作。